Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.31 USD | +2.84% | -0.63% | +32.24% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.24% | 2.29B | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
-55.31% | 2.99B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
-3.55% | 1.89B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Stephens Starts Myriad Genetics at Equalweight With $22 Price Target